◀ Back to ADCY4

ADCY4 — ADRB2

Text-mined interactions from Literome

Horinouchi et al., Eur J Pharmacol 2002 : In the presence of beta1- and beta2-adrenoceptor blockade, the potency ( pD2 value ) of catecholamines ( ( - ) -isoprenaline, ( - ) -noradrenaline and ( - ) -adrenaline ) and beta(3)-adrenoceptor agonists ( ( R*, R* ) - ( +/- ) -4- [ 2- [ ( 2- ( 3-chlorophenyl ) -2-hydroxyethyl ) amino ] propyl ] phenoxyacetic acid sodium ( BRL37344 ) and ( +/- ) - [ 4- [ 3- [ ( 1,1-dimethylethyl ) amino ] -2-hydroxypropoxy ] -1,3-dihydro-2H-benzimidazol-2-one ] hydrochloride ( ( +/- ) -CGP12177A ) ) to induce relaxation was not affected by the adenylate cyclase inhibitor, 9- ( tetrahydro-2-furanyl ) -9H-purin-6-amine ( SQ-22,536, 100 microM )
Krasnikova et al., Kardiologiia 1992 (Hypertension) : The effects of prostaglandin E2 ( PGE2 ) infusions on lymphocyte beta 2-adrenoceptor dependent adenylate cyclase ( beta 2ARAC ) system were studied in 26 patients with resistant hypertension ( RH )
Kashles et al., Biochem Pharmacol 1987 (Carcinoma, Squamous Cell) : Characterization of the beta 2-adrenoceptor dependent adenylate cyclase of A431 epidermoid carcinoma cells
Krasnikova et al., Tsitologiia 1994 : [ The effect of sodium and ouabain on the activation of beta 2-adrenoreceptor dependent adenylate cyclase in human lymphocytes ]
Gürdal et al., Mol Pharmacol 1997 : In previous studies, it was shown that the overexpression of beta2-adrenoceptor (beta2AR) in the hearts of transgenic mice ( Tg ) leads to agonist independent activation of adenylate cyclase and enhanced myocardial function